A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

RAD Technology Medical Systems to Provide VRCC Veterinary Specialty and Emergency Hospital with Standalone Radiotherapy Center

RAD Technology Medical Systems (RAD) is pleased to announce that they will be providing Veterinary Referral Center of Colorado, also know as, VRCC Veterinary Specialty and Emergency Hospital (VRCC) in Sheridan, CO with a veterinary radiotherapy center. This facility will allow VRCC to provide improved radiation therapy treatment to animals with cancer.

RAD’s patented technology and offsite modular construction methods provide their customers with a flexible, high-quality facility solution that is completed ahead of conventional construction.

RAD’s modular radiotherapy center was the perfect solution for the growing VRCC. They were looking for a quick solution that would allow them to upgrade their services in the region. They selected a pre-existing RAD facility that will be updated and expanded to meet all of their specific program needs.

Unlike with conventionally built radiotherapy centers, RAD’s facility and equipment will be able to make Beam within 5-7 days of its arrival on site, and will be ready to treat patients within 30 days of arrival.

This facility originally served as a Temporary Radiotherapy Vault, or RAD Temp, and was previously used by cancer centers from coast to coast, in five states and the District of Columbia, to treat patients while those cancer centers upgraded their radiotherapy equipment.

“We are excited to be entering the Veterinary Market,” said Kenneth Wright, RAD’s Vice President of Sales and Business Development. “The veterinary oncology market is growing and our modular approach is the perfect solution for veterinary offices looking to expand or add radiation treatment to their location.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy